A new triazine functionalized hexagonally ordered covalent organic polymer (TRITER-1) has been synthesized via the Schiff-base condensation reaction between a tailor made triamine 1,3,5-tris-(4-aminophenyl)triazine (TAPT) and terephthaldehyde. This ordered porous polymer showed a high BET surface area (716 m(2) g(-1)) and an excellent CO2 uptake capacity of 58.9 wt% at 273 K under 5 bar pressure.
Catalytic reduction of CO2 is very challenging from both economics and green chemistry perspectives. This critical review highlights major advancements made in the CO2 reduction processes and their future challenges.
The new covalent organic framework material TDFP-1 was prepared through a solvothermal Schiff base condensation reaction of the monomers 1,3,5-tris-(4-aminophenyl)triazine and 2,6-diformyl-4-methylphenol. Owing to its high specific surface area of 651 m g , extended π conjugation, and inherent microporosity, TDFP-1 exhibited an excellent energy-storage capacity with a maximum specific capacitance of 354 F g at a scan rate of 2 mV s and good cyclic stability with 95 % retention of its initial specific capacitance after 1000 cycles at 10 A g . The π-conjugated polymeric framework as well as ionic conductivity owing to the possibility of ion conduction inside the micropores of approximately 1.5 nm make polymeric TDFP-1 a favorable candidate as a supercapacitor electrode material. The electrochemical properties of this electrode material were measured through cyclic voltammetry, galvanic charge-discharge, and electrochemical impedance spectroscopy, and the results indicate its potential for application in energy-storage devices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.